Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is seeking a Senior Advisor, Regulatory Starting Material for an Associate Director level role. The position leads the strategy, justification, and regulatory positioning of Regulatory Starting Materials (RSMs) for drug substance manufacturing processes supporting late-stage clinical and commercial programs. Reporting to the Vice President, CMC, the role serves as an internal and external subject matter expert on RSM selection under ICH Q11 and applicable regional guidance. It ensures synthetic routes, GMP starting points, and supply strategies are scientifically sound, regulatorily defensible, and aligned with commercial manufacturing readiness. The Senior Advisor partners with Process Chemistry, Analytical Development, Regulatory Affairs, Quality, Supply Chain, Manufacturing, and external manufacturing partners to develop and defend RSM strategy in regulatory submissions and health authority interactions. The role also oversees starting material resupply and scale-up activities, supports technology transfer and manufacturing changes, manages relationships with API manufacturers and suppliers, and helps address risks affecting timelines, regulatory readiness, and commercial supply. Domestic and international travel of approximately 10–20% is required. The role is based in the US.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior